Search Results

There are 12407 results for: content related to: Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer

  1. You have full text access to this Open Access content
    Echinoderm microtubule-associated protein-like 4–anaplastic lymphoma kinase-targeted therapy for advanced non-small cell lung cancer: Molecular and clinical aspects

    Cancer Science

    Volume 103, Issue 8, August 2012, Pages: 1391–1396, Isamu Okamoto and Kazuhiko Nakagawa

    Version of Record online : 17 JUN 2012, DOI: 10.1111/j.1349-7006.2012.02327.x

  2. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations

    Genes, Chromosomes and Cancer

    Volume 51, Issue 10, October 2012, Pages: 925–932, Zhou Shaozhang, Lin Xiaomei, Zeng Aiping, He Jianbo, Song Xiangqun and Yu Qitao

    Version of Record online : 27 JUN 2012, DOI: 10.1002/gcc.21976

  3. You have full text access to this OnlineOpen article
    The evolving genomic classification of lung cancer

    The Journal of Pathology

    Volume 232, Issue 2, January 2014, Pages: 121–133, David S Shames and Ignacio I Wistuba

    Version of Record online : 10 DEC 2013, DOI: 10.1002/path.4275

  4. You have free access to this content
    Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer


    Volume 118, Issue 18, 15 September 2012, Pages: 4502–4511, Robert C. Doebele, Xian Lu, Christopher Sumey, DeLee A. Maxson, Andrew J. Weickhardt, Ana B. Oton, Paul A. Bunn Jr, Anna E. Barón, Wilbur A. Franklin, Dara L. Aisner, Marileila Varella-Garcia and D. Ross Camidge

    Version of Record online : 26 JAN 2012, DOI: 10.1002/cncr.27409

  5. Anaplastic lymphoma kinase translocation is correlated with anaplastic lymphoma kinase expression and mutually exclusive with epidermal growth factor receptor mutation in Taiwanese non-small cell lung cancer

    Pathology International

    Volume 65, Issue 5, May 2015, Pages: 231–239, Sheng-Chi Hsu, Tsai-Hsien Hung, Chih-Wei Wang, Kwai-Fong Ng and Tse-Ching Chen

    Version of Record online : 23 FEB 2015, DOI: 10.1111/pin.12268

  6. You have free access to this content
    Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement


    Volume 118, Issue 3, 1 February 2012, Pages: 729–739, Hye Ryun Kim, Hyo Sup Shim, Jin-Haeng Chung, Young Joo Lee, Yun Kyoung Hong, Sun Young Rha, Se Hoon Kim, Sang-Jun Ha, Se Kyu Kim, Kyung Young Chung, Ross Soo, Joo Hang Kim and Byoung Chul Cho

    Version of Record online : 30 JUN 2011, DOI: 10.1002/cncr.26311

  7. ALK gene rearranged lung adenocarcinomas: molecular genetics and morphology in cohort of patients from North India


    Volume 124, Issue 10, October 2016, Pages: 832–838, Amanjit Bal, Navneet Singh, Parimal Agarwal, Ashim Das and Digambar Behera

    Version of Record online : 8 AUG 2016, DOI: 10.1111/apm.12581

  8. You have free access to this content
    Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never-smoker women with pulmonary adenocarcinoma


    Volume 118, Issue 22, 15 November 2012, Pages: 5588–5594, Shengxiang Ren, Xiaoxia Chen, Peng Kuang, Limou Zheng, Chunxia Su, Jiayu Li, Bing Li, Yongshen Wang, Lu Liu, Qiong Hu, Jie Zhang, Liang Tang, Xuefei Li, Caicun Zhou and Gerald Schmid-Bindert

    Version of Record online : 8 MAY 2012, DOI: 10.1002/cncr.27603

  9. You have free access to this content
    Cytomorphological features of ALK-positive lung adenocarcinomas: Psammoma bodies and signet ring cells

    Cancer Cytopathology

    Volume 123, Issue 3, March 2015, Pages: 162–170, Fresia Pareja, John P. Crapanzano, Mahesh M. Mansukhani, William A. Bulman and Anjali Saqi

    Version of Record online : 29 DEC 2014, DOI: 10.1002/cncy.21507

  10. You have free access to this content
    Implementation of modern therapy approaches and research for non-small cell lung cancer in Japan


    Volume 20, Issue 2, February 2015, Pages: 199–208, Yoichi Nakanishi

    Version of Record online : 16 JAN 2015, DOI: 10.1111/resp.12460

  11. You have full text access to this OnlineOpen article
    Sufficiency of Single-Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib

    Clinical and Translational Science

    Volume 9, Issue 2, April 2016, Pages: 63–73, P Selaru, Y Tang, B Huang, A Polli, KD Wilner, E Donnelly and DP Cohen

    Version of Record online : 1 MAR 2016, DOI: 10.1111/cts.12388

  12. You have free access to this content
    Novel targeted agents for the treatment of lung cancer in China


    Volume 121, Issue S17, September 1, 2015, Pages: 3089–3096, Si-Yang Liu, Tony Mok and Yi-Long Wu

    Version of Record online : 1 SEP 2015, DOI: 10.1002/cncr.29522

  13. Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALKFISH probe testing


    Volume 67, Issue 5, November 2015, Pages: 654–663, Christina Selinger, Wendy Cooper, Trina Lum, Catriona McNeil, Adrienne Morey, Paul Waring, Benhur Amanuel, Michael Millward, Joanne Peverall, Chris Van Vliet, Michael Christie, Yen Tran, Connie Diakos, Nick Pavlakis, Anthony J Gill and Sandra O'Toole

    Version of Record online : 24 MAY 2015, DOI: 10.1111/his.12708

  14. Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non–small cell lung cancer


    Volume 123, Issue 15, August 01, 2017, Pages: 2927–2935, Limin Zhang, Tao Jiang, Xuefei Li, Yan Wang, Chao Zhao, Sha Zhao, Lei Xi, Shijia Zhang, Xiaozhen Liu, Yijun Jia, Hui Yang, Jinpeng Shi, Chunxia Su, Shengxiang Ren and Caicun Zhou

    Version of Record online : 27 MAR 2017, DOI: 10.1002/cncr.30677

  15. You have free access to this content
    Preparing for tomorrow: Molecular diagnostics and the changing nonsmall cell lung cancer landscape

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue S2, April 2014, Pages: 2–10, Michael Boyer, Ming-Sound Tsao, Pasi Jänne, Suresh Ramalingam, Susan Pitman Lowenthal and Mahmood Alam

    Version of Record online : 28 MAR 2014, DOI: 10.1111/ajco.12189

  16. Current Status of Targeted Therapy for Anaplastic Lymphoma Kinase–Rearranged Non–Small Cell Lung Cancer

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 1, January 2014, Pages: 15–23, B Solomon, KD Wilner and AT Shaw

    Version of Record online : 19 DEC 2013, DOI: 10.1038/clpt.2013.200

  17. Detection of ALK expression in non-small-cell lung cancer with ALK gene rearrangements – comparison of multiple immunohistochemical methods


    Volume 65, Issue 4, October 2014, Pages: 539–548, Karen Zwaenepoel, Amber Van Dongen, Suzan Lambin, Christine Weyn and Patrick Pauwels

    Version of Record online : 6 AUG 2014, DOI: 10.1111/his.12414

  18. Targeting ALK Rearrangements

    Lung Cancer, Fourth Edition

    Justin F. Gainor, Alice T. Shaw, Pages: 541–556, 2014

    Published Online : 4 APR 2014, DOI: 10.1002/9781118468791.ch35

  19. You have full text access to this Open Access content
    Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

    Journal of Cellular and Molecular Medicine

    Volume 14, Issue 1-2, January-February 2010, Pages: 51–69, Luis Paz-Ares, Denis Soulières, Ivan Melezínek, Joachim Moecks, Lorenz Keil, Tony Mok, Rafael Rosell and Barbara Klughammer

    Version of Record online : 8 DEC 2009, DOI: 10.1111/j.1582-4934.2009.00991.x

  20. You have full text access to this OnlineOpen article
    Poor response to gefitinib in lung adenocarcinoma with concomitant epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement

    Thoracic Cancer

    Volume 6, Issue 2, March 2015, Pages: 216–219, Jianya Zhou, Jing Zheng, Jing Zhao, Yihong Sheng, Wei Ding and Jianying Zhou

    Version of Record online : 2 MAR 2015, DOI: 10.1111/1759-7714.12146